Methyl-CpG-binding protein 2 (MeCP2) is a key transcriptional regulator that can induce either silencing or activation of target genes. Genetic polymorphisms in the MECP2/IRAK1 locus have been associated with increased susceptibility to multiple autoimmune diseases such as lupus, primary Sjogren's syndrome, and more recently rheumatoid arthritis. Data from our group suggest that the disease risk variant in this locus is associated with gain of MeCP2 function. Recent findings indicate that MECP2 duplication in humans results in defective T helper cell type 1 (T H 1) response and IFN-g production. Herein, we discuss the data from children with MECP2 duplication, human lupus, and from the human MECP2 transgenic and Mecp2 deficient mice to support a link between MECP2 overexpression and autoimmunity. We also provide findings from an Mecp2 deficient mouse that independently support a role for MeCP2 in the immune response and specifically in IFN-g expression.
Abnormal DNA methylation, particularly in T cells, plays an important role in the pathogenesis of systemic lupus erythematosus, a multi-system autoimmune disease characterized by the production of autoantibodies to nuclear antigens. 1, 2 We have previously identified, replicated, and confirmed that genetic variants within MECP2 increase the susceptibility to lupus. [3] [4] [5] While MECP2 expression was shown to be reduced in total PBMCs in the presence of the lupus risk variant, 6 recent data suggest that the lupus-associated variant in MECP2 is associated with increased MECP2 isoform 2 mRNA expression in stimulated but not unstimulated T cells, 7 and that the human MECP2 transgenic mice develop antinuclear antibodies. 7 The lupus risk variant in MECP2 is also associated with significant DNA hypomethylation in multiple interferon-regulated genes in stimulated T cells, 7 supporting our earlier studies that demonstrated increased expression of interferon-regulated genes in lymphoblastoid cell lines in lupus patients with the MECP2 risk variant. 4 A recent study by Yang and colleagues identified a defect in T H 1 response and the production of IFN-g is children with a neurodevelopmental disease caused by MECP2 duplication. 8 These data were also supported by findings from a transgenic mouse that overexpresses human MECP2. 8 We have studied female mice homozygous for a targeted truncating mutation in Mecp2 (B6.129S-Mecp2 tm1Hzo /J) crossed onto the C57BL/6 background. These mice were developed by inserting a stop codon after codon 308 in Mecp2.
9 Splenic mouse T cells were isolated at 12 weeks of age by magnetic beads via indirect labeling (Milteny), and T cell stimulation was achieved using PMA and ionomycin. RNA was extracted from stimulated T cells from Mecp2 deficient and C57BL/6 ageand sex-matched control mice. Gene expression experiments in five mice from each strain were performed using Illumina expression arrays. We compared mRNA expression profiles between T cells from Mecp2 deficient mice and C57BL/6 controls and detected a number of upregulated and downregulated transcripts (Table 1) . Importantly, stimulated T cells from Mecp2 deficient mice showed increased expression of IFN-g mRNA transcript. This is consistent with and supports the findings of Yang et al. that MECP2 duplication is associated with reduced IFN-g response. 8 In addition, we observed significant overexpression of chemokine (C-C motif) ligand 5 (Ccl5) and colony stimulating factor 2 (Csf2) in Mecp2 deficient mice. CCL5 (also known as RANTES) is involved in T cell differentiation and particularly the activation and function of T H 1 immune response.
10 CCL5 deficiency results in increased susceptibility to infections, notably pneumonia, 11 which is observed in increased frequency in children with MECP2 duplication. 8 Indeed, CCL5 blockade impairs IFN-g production and enhances the expression of the immunosuppressive cytokine IL-10 by T cells.
10
CCL5 also plays an important role in suppressing viral infections.
12 Csf2 (GM-CSF) plays an important role in granulocytes and macrophage differentiation and function. Interestingly, the expression of IFN-g and Csf2 is regulated by DNA methylation, 13, 14 and MeCP2 is known to mediate DNA methylation-induced transcriptional regulation and to recruit DNA methyltransferase 1 for the maintenance of methylation during DNA synthesis. 15 Although MECP2 and the adjacent gene IRAK1 are in strong linkage disequilibrium, we did not detect any change in IRAK1 expression with the lupus-associated variant in this locus in stimulated T cells. 7 It was previously suspected that the susceptibility to infection in patients with MECP2 duplication may be related to IRAK1, which is also frequently duplicated in MECP2 duplication syndrome. Indeed, IRAK1 plays an important role in both the innate and the adaptive immune response. The recent data by Yang and colleague, however, shed light on this question and indicate that the immune defects observed in these patients are explained by overexpression of MECP2 and are independent of IRAK1 duplication. 8 Lupus is a disease characterized by B cell activation and antinuclear antibody production, suggesting an important role for T H 2 T cell differentiation in the disease pathogenesis. Upon stimulation, the percentage of IFN-g-expressing CD4 þ T cells in PBMCs is significantly lower in lupus patients compared with healthy controls, 16 similar to children with MECP2 duplication. 8 Nonetheless, T H 1 effector cells and IFN-g production within target tissue play an important role in organ damage in lupus, particularly in the onset and progression of glomerulonephritis. 17 Indeed, autoantibodies against ribosomal P, which are associated with lupus nephritis, have been shown to induce IFN-g production. 18 Yang et al. reported an attenuated IgG response after boost vaccination in some children with MECP2 duplication, consistent with previous reports, and also consistent with recent findings in lupus patients that showed attenuated response to influenza vaccination in a subset of lupus patients. 19 The presence of immature neutrophils, and IgA deficiency are other immunological features common to both MECP2 duplication and lupus. 20, 21 There is a significantly higher incidence of a variety of autoimmune diseases in patients with IgA deficiency and shared genetic susceptibility loci between IgA deficiency and autoimmunity. 21 Total circulating B cells are often reduced in lupus patients, as has been also reported in a subset of patients with MECP2 duplication. 8, 22 However, while lupus patients often demonstrate an expanded memory B cell subset, memory B cells were reduced in patients with MECP2 duplication. Other notable differences include increased naı¨ve CD4 þ T cells and reduced antigen-experienced CD4 þ T cells in patients with MECP2 duplication, which is in contrast to lupus. Lupus patients are characterized by the presence of autoreactive T cells and loss of T cells tolerance, resulting in expansion of the antigen-experienced CD4 þ T cell compartment, accumulation of terminally differentiated memory T cells, and a decrease of naı¨ve CD4 þ T cells over the course of the disease. 23, 24 In summary, we provide evidence to further support a role for MeCP2 in T H 1 differentiation. We discuss data that suggest that MECP2 duplication might be associated with increased susceptibility to autoimmunity and highlight some similarities in the immune dysfunction observed in patients with MECP2 duplication syndrome and lupus. Future studies to explore the occurrence and spectrum of autoimmunity in MECP2 overexpression and to understand the functional role of MECP2 variants and overexpression upon lupus susceptibility are warranted.
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